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2,8-Dihydroxy adenine urolithiasis is a rare but probably un­
der diagnosed disorder1'2 that may ultimately lead to chronic 
renal failure caused by recurrent stone formation.3”8 In this 
hereditary condition stones form due to a homozygote adenine 
phosphoribosyltransferase deficiency that makes conversion of 
adenine to adenine monophosphate impossible. Instead of ade­
nine monophosphate, insoluble 8-hydroxy adenine and 2,8- 
dihydroxyadenine are formed. Inhibition of xanthine oxidase 
activity with allopurinol prevents the conversion of adenine to 
8-hydroxyadenine and 2,8-di hydroxy adenine, effectively inhib­
iting 2,8-dihydroxyadenine crystal and stone formation.1* 3>5’6 
We report on a renal transplant recipient with a history of 
urolithiasis and 2,8-dihydroxyadenine crystal formation in the 
renal graft.
CASE REPORT
A 56-year-old man on peritoneal dialysis had a history of 
recurrent radiolucent and radiopaque urolithiasis of sup­
posed uric acid composition, necessitating 9 surgical inter­
ventions between the ages of 16 and 41 years. At the end of 
this period endogenous creatinine clearance was 84 mL per 
minute. Subsequently during 15 years of treatment with 
allopurinol only 1 renal stone developed but renal function 
gradually decreased, probably because of frequently recur­
ring pyelonephritis.
Renal transplantation was performed and allopurinol was 
discontinued. Biopsy of the renal graft was obtained on day
10 postoperatively because of oliguria. Little sign of rejection 
or cyclosporine nephrotoxicity was noted but there were 
many round yellow-brownish crystals of various sizes in the 
tubular lumina, epithelial cells and inters titium, where they 
were sometimes surrounded by macrophages and an occa­
sional giant cell (part A of figure). Under polarized light the 
crystals appeared to be birefringent and composed of radially 
arranged fine needles (part B of figure). This material was 
also observed in urinary sediment. Serum level and urinary 
excretion of uric acid were normal. After conversion of cyclo-
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Biopsy of renal transplant. A, crystalline material in interstitium 
and tubuli. B t same area under polarized light, Methenamine silver 
stain, reduced from X420.
sporine to azathioprine maximal endogenous creatinine 
clearance was only 32 ml. per minute.
Biopsies on days 27 and 51 showed acute interstitial rejec­
tion with tubulointerstitial damage in addition to crystals. 
Despite antirejection treatments hemodialysis had to be 
started on day 80. The graft was removed 6 months later with 
signs of chronic vascular rejection and diffuse deposition of 
crystals. Biopsy of the contralateral kidney of the donor ob­
tained because of insufficient renal transplant function 
showed signs of cyclosporine nephrotoxicity and mild vascu­
lar rejection but no crystals.
2,8-Dihydroxyadenine urolithiasis was suspected on crys­
tal morphology and confirmed by detection of 2,8-dihy­
droxyadenine on high performance liquid chromatography in 
urine and serum, and on crystal analysis by x-ray diffraction 
microanalysis. Mean adenine phosphoribosyltransferase ac­
tivity in lymphocytes plus or minus standard deviation was
0.7 ± 0.6 nmol./106 cells per hour (normal 13.6 ± 0.9) in our 
patient, in the normal range in his brother, and intermediate 
in his 2 sisters and 2 children (11.9 ± 0.9 and 4.7 to 5.8 
nmol./106 cells per hour, respectively), 2,8-Dihydroxy adenine 
was not measurable in urine samples from these relatives. 
The data support the hereditary homozygous character of
2,8-dihydroxyadenine urolithiasis due to adenine phosphori­
bosyltransferase deficiency.1
DISCUSSION
Our patient had a long history of urolithiasis. After 
renal transplantation 2,8-dihydroxyadenine crystals in the 
renal graft led to considerable destruction of the graft, although 
a role for other factors, such as rejection, cannot be excluded. 
Only a few other cases with 2,8-dihydroxyadenine crystal for­
mation in a renal graft have been reported.1«5»9 In general,
2,8-dihydroxyadenine urolithiasis is a rare but under diagnosed 
disorder.1 Due to chemical similarity 2,8-dihydroxyadenine can 
easily be mistaken for uric acid.1 Therefore, in our patient stone 
formation was probably initially due to 2,8-dihydroxy- 
adeninuria, resulting in renal failure. Also, the prevention of 
new stone formation after the start of allopurinol therapy sup­
ports 2,8-dihydroxyadenine stone formation from the outset.
CONCLUSIONS
Since new stone formation can be prevented with allopuri­
nol,1*5 early diagnosis of 2,8-dihydroxyadenine urolithiasis is 
warranted and it can be suggested by the aspect of the crystals 
in urine. The diagnosis can be made by analysis of crystal or 
stone composition, and confirmed by measurement of 2,8- 
dihydroxyadenine levels in urine and serum, and adenine phos­
phoribosyltransferase activity in lymphocytes. The risk in 
family members can be assessed by measuring adenine phos­
phoribosyltransferase activity in the lymphocytes.
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